In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aridis Pharmaceuticals Inc.

www.aridispharma.com

Latest From Aridis Pharmaceuticals Inc.

Italfarmaco Options Inhaled Teicoplanin For MRSA Lung Infections

Italfarmaco and Neupharma plan to collaborate on the development of a new inhaled formulation of a Gram-positive targeted antibiotic for MRSA infections in cystic fibrosis.

 

Deals Infectious Diseases

Keeping Track: Some Calm Before The Storm

The latest drug development news and highlights from our US FDA Performance Tracker.

Drug Review Approvals

Finance Watch: Vaccinex, Aridis Launch August's First US IPOs As The Summer Simmer Slows

The summer slowdown finally seems to have hit the US biopharma IPO market; after a hot July with nine offerings, there were just two during the first half of August. Also, Zogenix leads recent follow-ons with a $312m offering; venture capital planted in UK biotechs – Orchard and Blueberry.

Financing Business Strategies

WHO Publishes List Of Pathogen Threats To Rouse Drug Developers

The World Health Organisation has released a list of 12 bacteria it says pose the greatest threat to human health as a way of urging governments and the drug development industry to incentivize and launch an R&D response against the increasing global issue of antibiotic resistance.

Research and Development Strategies Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aridis Pharmaceuticals Inc.
  • Senior Management
  • Vu L Truong, PhD, CEO
    Fred Kurland, CFO
    Wolfgang Dummer, MD, PhD, CMO
  • Contact Info
  • Aridis Pharmaceuticals Inc.
    Phone: (408) 385-1742
    5941 Optical Ct.
    San Jose, CA 95138
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register